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We	characterized	Middle	East	 respiratory	syndrome	coro-
naviruses	from	a	hospital	outbreak	in	Jordan	in	2015.	The	
viruses	 from	 Jordan	 were	 highly	 similar	 to	 isolates	 from	
Riyadh,	Saudi	Arabia,	except	for	deletions	in	open	reading	
frames	4a	and	3.	Transmissibility	and	pathogenicity	of	this	
strain	remains	to	be	determined.
Middle East respiratory syndrome coronavirus (MERS-CoV) was first recognized in 2012 as the cause of 
severe lower respiratory tract infection in humans (1). As 
of November 13, 2015, a total of 1,618 cases of laboratory-
confirmed MERS-CoV infection and 579 associated deaths 
had been reported to the World Health Organization (2). 
Human-to-human transmission of MERS-CoV can occur 
in households and hospitals, but thus far, major genomic 
changes associated with host switching, as have occurred 
with severe acute respiratory syndrome (SARS) CoV, have 
not been noted for MERS-CoV (3–9). We characterized 
MERS-CoVs from a recent hospital outbreak in Jordan. 
The Study
During August and September 2015, an outbreak of MERS-
CoV infection occurred in hospitals in Jordan (10). MERS-
CoV–positive throat swab or bronchiolar lavage samples 
were obtained from each patient; of these, 13 samples 
were labeled Jordan-1-2015 through Jordan-13-2015 and 
shipped on dry ice to Erasmus University Medical Center 
(Rotterdam, the Netherlands) for testing. Total RNA was 
isolated from 140 μL of each sample by use of a QIAamp 
Viral RNA Mini Kit (QIAGEN, Hilden, Germany) and 
quantified by TaqMan assay targeting the envelope gene, 
as described previously (11). Full MERS-CoV genome se-
quencing was performed on the sample with the highest 
viral load, obtained on August 24, 2015, from a 60-year-old 
man who died of the disease 3 days later. At the end of July 
2015, this man had traveled from Jeddah, Saudi Arabia, to 
Jordan for his annual vacation. From the throat swab sam-
ple from this man, 76,082 sequence reads—of which 851 
were specific for MERS-CoV—were obtained by using 454 
deep-sequencing (12), revealing ≈85% of the MERS-CoV 
genome with coverage of 1–178 reads at single-nucleotide 
positions. Missing sequences and low-coverage regions 
were obtained by conventional Sanger sequencing, except 
for 6 nt at the 5′ end.
Phylogenetic analysis of the complete viral genome 
of this sample revealed that this virus, tentatively called 
Jordan-1-2015, clusters with viruses detected in humans in 
Riyadh in 2015 (Figure 1). Alignment of the full genom-
ic sequences of this virus with the Riyadh 2015 isolates 
showed that they were >99.7% similar. Amino acids in 
the spike protein were the same in Jordan-1-2015 and the 
consensus sequence of the Riyadh 2015 viruses. Of note, 
Jordan-1-2015 contained a 48-nt (16 aa) in-frame deletion 
in open reading frame (ORF) 4a that had not been detected 
in any other MERS-CoV (Figure 2, panel A). This ORF is 
present only in lineage 2c betacoronaviruses and encodes 
protein 4a, which has recently been shown to inhibit type 
I interferon production, presumably by binding and mask-
ing double-stranded RNA from detection by RNA sensors 
such as RIG-1 (retinoic acid–inducible gene 1)–like heli-
cases and the double-stranded RNA-binding protein PACT 
(protein activator of the interferon-induced protein kinase) 
(13,14). Subsequent sequence analysis showed that all 13 
viruses from patients sampled during this outbreak con-
tained the deletion and that the flanking regions were iden-
tical, indicating that this deletion mutant was transmitted 
(Figure 2, panel B).
To further characterize the viruses in the clinical 
samples, we subjected all samples to titration on Vero 
cells (American Type Culture Collection no. CCL-81). 
We observed cytopathic changes in cells inoculated with 
samples Jordan-1-2015 and Jordan-10-2015 (obtained 
on September 17 from a 29-year-old man, who survived 
the illness); however, no cytopathic changes were ob-
served in the cells inoculated with the other samples. 
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Subsequently, we obtained complete genomes by deep 
sequencing of the second-passage viruses, with high 
coverage of reads at single-nucleotide positions. No cell 
culture adaptive mutations in the genome sequence were 
observed for the virus isolated from clinical sample Jor-
dan-1-2015. Pairwise comparison of Jordan-1-2015 with 
Jordan-10-2015 revealed that both viruses were highly 
similar (99.99% nt identity) and confirmed that both 
carried the 48-nt deletion in ORF4a. However, in ad-
dition to this deletion, a 9-nt (3-aa) in-frame deletion 
was observed in the genome of Jordan-10-2015. This 
deletion was located in ORF3, which encodes a protein 
with an unknown function. The presence of this deletion 
in the virus from clinical sample Jordan-10-2015 was 
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Figure 1.	Phylogenetic	analysis	of	
Middle	East	respiratory	syndrome	
coronavirus	(MERS-CoV)	isolated	
from	Jordan	(Jordan-1-2015;	boldface)	
compared	with	reference	strains.	
Genome	sequences	of	representative	
isolates	were	aligned	by	using	
ClustalW,	and	a	phylogenetic	tree	
was	constructed	by	using	the	PhyML	
method	in	Seaview	4	(http://pbil.univ-
lyon1.fr/software/seaview);	the	tree	was	
visualized	by	using	FigTree	version	
1.3.1	(http://tree.bio.ed.ac.uk/software/
figtree).	Values	at	branches	show	the	
result	of	the	approximate	likelihood	
ratio;	values	<0.70	are	not	shown.	Scale	
bar	indicates	nucleotide	substitutions	
per	site.
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confirmed by Sanger sequencing, excluding the pos-
sibility that it was an adaptation to cell culture. Next, 
sequencing of ORF3 from all other clinical samples re-
vealed that the ORF3 deletion was present in a subgroup 
of clinical samples (Figure 2, panel C). These samples 
had been collected toward the end of the outbreak, sug-
gesting that the ORF3 deletion may be an adaptation 
resulting from sustained transmission between humans. 
All sequences obtained in this study were deposited in 
GenBank (accession nos. KU233362–KU233377). Iden-
tical deletions in ORF3 and ORF4a in the same sample 
set from Jordan were independently confirmed by Eras-
mus University Medical Center and the Centers for Dis-
ease Control and Prevention (Atlanta, GA, USA).
Conclusions
Despite the human-to-human transmission capacity of 
MERS-CoV and substantial sequencing efforts, major ge-
nomic changes associated with human adaptation have not 
been described (3–8). We observed a large-scale deletion in 
ORF4a and a small deletion in ORF3 in MERS-CoVs that 
caused the outbreak in Jordan. 
One of the most striking genomic changes observed in 
SARS-CoV isolated from humans soon after its transmis-
sion from animals was the acquisition of a 29-nt deletion 
in ORF8, an accessory protein with an unresolved function 
(9). The SARS-CoV ORF8 deletion disrupted the reading 
frame of the early-stage human isolates and created 2 new 
ORFs, designated ORF8a and ORF8b. Although no clear 
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Figure 2. Genomic 
characterization	of	Middle	
East	respiratory	syndrome	
coronaviruses	(MERS-CoVs)	from	
Jordan.	A)	Nucleotide	differences	
between	MERS-CoV	strain	
Jordan-1-2015	and	the	consensus	
sequence	of	the	Riyadh	2015	
cluster.	Nucleotide	changes	are	
indicated	by	vertical	lines	in	bar.	
B)	Protein	sequence	alignment	
of	open	reading	frame	(ORF)	4a	
(residues	10–76)	of	all	13	MERS-
CoV	strains	from	Jordan	in	2015	
compared	with	the	consensus	
sequence	of	the	Riyadh	2015	
cluster.	No	nucleotide	substitutions	
were	observed	in	this	region	
between	MERS-CoVs	from	Jordan.	
Predicted	secondary	structures	
are	indicated	(13).	Classical	
double-stranded	RNA	binding	
proteins	have	αβββα	architecture.	
C)	Protein	sequence	alignment	
of	ORF3	(residues	25–77)	of	
all	13	MERS-CoV	strains	from	
Jordan	in	2015	compared	with	
the consensus sequence of the 
Riyadh	2015	cluster.	No	nucleotide	
substitutions	were	observed	in	
this	region	between	MERS-CoVs	
from	Jordan.	Alignments	were	
generated	with	the	ClustalW	
program	(http://pbil.univ-lyon1.fr/
software/seaview)	and	visualized	
by	using	Jalview	2.9	(http://www.
jalview.org/).	Boxes	in	panels	B	
and	C	indicate	regions	where	
amino	acids	have	been	deleted	in	
the	viruses	from	Jordan.
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roles have been designated for both ORFs, viruses contain-
ing this deletion predominated later during the epidemic, 
showing that these viruses were able to spread efficiently 
from human to human. 
The deletion we describe in ORF4a of MERS-CoV 
does not result in the removal of an entire gene, because the 
reading frame is not disrupted, suggesting that this mutation 
is not a loss-of-function mutation. However, whether this 
ORF4a deletion variant can still bind double-stranded RNA 
needs to be assessed because the deleted region contains a 
predicted β-sheet belonging to the classical double-strand-
ed RNA binding αβββα fold of this protein (13; Figure 2, 
panel B). The data from this study indicate that adaptive 
pressures possibly exerted by the human host may operate 
on the ORF4a and ORF3 regions. Alternatively, proteins 
encoded by these ORFs could have functions specific for 
the camel host, causing them to be redundant in humans 
and enabling accumulation of mutations that do not affect 
viral fitness in humans. Future studies of the roles of these 
proteins are needed.
The deletion located in the type I interferon antago-
nist protein 4a was detected in all samples collected during 
the outbreak. Another small-scale deletion was detected 
in ORF3 in a subset of samples collected later in the out-
break. Overall, the data suggest that MERS-CoV ORF4a 
and ORF3 can acquire deletions by selection or by chance. 
Whether these deletions affect the transmissibility or patho-
genicity of this particular MERS-CoV strain needs to be 
addressed. The finding that all viruses analyzed contained 
the ORF4a deletion suggests that all patients were infected 
with the same virus. Although unlikely, some MERS pa-
tients may have indirectly become infected through inde-
pendent transmission of viruses in dromedaries carrying 
highly related viruses, some of which acquired deletions 
in their genome. Therefore, a more detailed epidemiologic 
investigation of this outbreak is needed. These data under-
score the need for close monitoring of the molecular evolu-
tion of MERS-CoV.
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